ArticleFrontiers in oncology2019
Germline Predisposition and Copy Number Alteration in Pre-stage Lung Adenocarcinomas Presenting as Ground-Glass Nodules.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 26% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Molecular Alterations in Lung Adenocarcinoma With Ground-Glass Nodules: A Systematic Review and Meta-Analysis.Frontiers in oncology · 2021Pooled it
- Review
- The clinical, radiological, postoperative pathological, and genetic features of nodular lung adenocarcinoma: a real-world single-center data.Journal of thoracic disease · 2024Article
- Multidimensional biological characteristics of ground glass nodules.Frontiers in oncology · 2024Review
- Article
- The microbiome of lower respiratory tract and tumor tissue in lung cancer manifested as radiological ground-glass opacity.Frontiers in bioengineering and biotechnology · 2022Article
- Airway Microbiota in Patients With Synchronous Multiple Primary Lung Cancer: The Bacterial Topography of the Respiratory Tract.Frontiers in oncology · 2022Article
- Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma.Neoplasia (New York, N.Y.) · 2021Article
- Genomic landscape of ground glass opacities (GGOs) in East Asians.Journal of thoracic disease · 2021Article
- Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?OncoTargets and therapy · 2021Article
- Application of large-scale targeted sequencing to distinguish multiple lung primary tumors from intrapulmonary metastases.Scientific reports · 2020Article
- Mutational Pattern in Multiple Pulmonary Nodules Are Associated With Early Stage Lung Adenocarcinoma.Frontiers in oncology · 2020Article
- Multiple Primary Lung Cancers: A New Challenge in the Era of Precision Medicine.Cancer management and research · 2020Review
- Whole genome sequencing revealed microbiome in lung adenocarcinomas presented as ground-glass nodules.Translational lung cancer research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 14 institutions in 3 countries.
Yijiu RenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Shujun HuangResearch Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
Chenyang DaiDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Dong XieDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Larry ZhengResearch Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
Huikang XieDepartment of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Hui ZhengDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Yunlang SheDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Fangyu ZhouDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Yue WangNovogene Bioinformatics Technology Institute, Beijing, China.
Pengpeng LiNovogene Bioinformatics Technology Institute, Beijing, China.
Ke FeiDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Gening JiangDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Yang ZhangResearch Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
Bo SuLaboratory center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
E Alejandro Sweet-CorderoDivision of Hematology and Oncology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, United States.
Nhan Le TranDepartments of Cancer Biology, Mayo Clinic Arizona, Scottsdale, AZ, United States.
Yanan YangThoracic Disease Research Unit, Division of Pulmonary and Critical Care Medicine, Developmental Therapeutics and Cell Biology Programs, Department of Biochemistry and Molecular Biology, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN, United States.
Jai N PatelDivision of Hematology/Oncology, Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, United States.
Christian RolfoThoracic Medical Oncology, Experimental Therapeutics Research Program, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, United States.
Gaetano RoccoThoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY, United States.
Andrés Felipe CardonaThoracic Oncology Unit, Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.
Alessandro TuziMedical Oncology, ASST Sette Laghi, Varese, Italy.
Matteo B SuterMedical Oncology, ASST Sette Laghi, Varese, Italy.
Ping YangDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.
Wayne XuResearch Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
Chang ChenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Tongji University · CNShanghai Pulmonary Hospital · CNAziende Socio Sanitarie Territoriale dei Sette LaghiNovogene Bioinformatics Institute · CNResearch Institute in Oncology and Hematology · CACancerCare Manitoba · CALevine Cancer Institute · USMayo Clinic in Arizona · USMayo Clinic in Florida · USMemorial Sloan Kettering Cancer Center · USUniversity of California, San Francisco · USUniversity of Manitoba · CAUniversity of Maryland, Baltimore · USWinnMed · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
copy number variationdriver mutationsground-glass nodulelung cancerwhole-exome sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.